Skip to main content
Premium Trial:

Request an Annual Quote

Evogene's Q3 Revenues Rise Sharply, Swings to Profit

NEW YORK (GenomeWeb News) – Evogene today reported that its third-quarter revenues increased nearly three-fold year over year, and it swung to a profit from a loss.

The Rehovot, Israel-based firm reported total revenues of $2.6 million for the three-month period ended Sept. 30, 2009, compared to $870,000 for the third quarter of 2008.

It posted a profit of $2.1 million, or $.07 per share, compared to a net loss of $7.1 million, or $.35 per share, for the third quarter of 2008. Last year's Q3 included a non-cash financial charge of $4.8 million due to the revaluation of options associated with the firm's 2007 initial public offering.

Evogene's R&D expenses declined to $741,000 from $2 million year over year, while its business development expenses dropped to $178,000 from $400,000, and its general and administrative spending increased to $393,000 from $344,000.

Evogene has developed a computational gene discovery platform, called the Athlete, which it uses in its research on plant traits and improvement of plants for biofuel uses.

The firm finished the quarter with $39 million in cash, cash equivalents, cash deposits, and short-term marketable securities.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.